New Zealand markets closed

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
17.33-0.47 (-2.64%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 19.74B
Enterprise value 21.15B
Trailing P/E 20.15
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.81
Price/book (mrq)2.71
Enterprise value/revenue 0.83
Enterprise value/EBITDA 13.31

Trading information

Stock price history

Beta (5Y monthly) 0.20
52-week change 3-38.89%
S&P500 52-week change 323.76%
52-week high 330.22
52-week low 317.16
50-day moving average 321.16
200-day moving average 323.70

Share statistics

Avg vol (3-month) 37.37M
Avg vol (10-day) 38.63M
Shares outstanding 51.14B
Implied shares outstanding 61.14B
Float 8403.57M
% held by insiders 166.56%
% held by institutions 112.35%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 43.09%
Trailing annual dividend rate 30.31
Trailing annual dividend yield 31.74%
5-year average dividend yield 41.45
Payout ratio 469.77%
Dividend date 3N/A
Ex-dividend date 409 Jun 2023
Last split factor 21.2:1
Last split date 309 Jun 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 4.22%
Operating margin (ttm)9.32%

Management effectiveness

Return on assets (ttm)4.50%
Return on equity (ttm)14.46%

Income statement

Revenue (ttm)25.34B
Revenue per share (ttm)22.41
Quarterly revenue growth (yoy)13.50%
Gross profit (ttm)N/A
EBITDA 1.89B
Net income avi to common (ttm)1.07B
Diluted EPS (ttm)0.86
Quarterly earnings growth (yoy)-19.80%

Balance sheet

Total cash (mrq)5.4B
Total cash per share (mrq)4.74
Total debt (mrq)6.81B
Total debt/equity (mrq)80.51%
Current ratio (mrq)0.97
Book value per share (mrq)6.41

Cash flow statement

Operating cash flow (ttm)3.65B
Levered free cash flow (ttm)3.17B